The first digital pill with ingestible sensor Approved by US FDA - Digital Intent

PHARMA HEALTHCARE BIOTECH DIGITAL NEWS & VIEWS

Thursday, 16 November 2017

The first digital pill with ingestible sensor Approved by US FDA



The product, Abilify MyCite (aripiprazole tablets with sensor), was approved on Monday for the treatment of schizophrenia, bipolar disorder and for use as an add-on treatment for depression in adults.

The system works by sending a message from the pill's sensor to a wearable patch. The patch transmits the information to a mobile application so that patients can track the ingestion of the medication on their smartphone, the FDA said in a statement.

Patients can also permit their caregivers and physician to access the information through a web-based portal.


The approval of the so-called digital pill is expected to increase adherence to medication.
"The FDA supports the development and use of new technology in prescription drugs and is committed to working with companies to understand how technology might benefit patients and prescribers," Mathis said.

No comments:

Post a Comment